Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Yan Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Receptor, Metabotropic Glutamate 5, Alzheimer Disease, tau Proteins, Hippocampus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, National Science Foundation of China, Shanghai Sailing Program.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION To investigate the associations of metabotropic glutamate receptor 5 (mGluR5) with tau deposition and cognitive ability in patients with early Alzheimer's disease (AD). METHODS Twenty‐six cognitively impaired (CI) and 14 cognitively unimpaired (CU) individuals underwent mGluR5 positron emission tomography (PET) ([ 18 F]PSS232), amyloid PET ([ 18 F]florbetapir), and tau PET ([ 18 F]MK6240), and neuropsychological assessment. The relationships among mGluR5 availability, tau deposition, and neuropsychological assessment were analyzed using Spearman's correlation and mediation analyses. RESULTS CI patients had lower mGluR5 in the hippocampus than CU (standardized uptake value ratio [SUVr]: 2.03 ± 0.25 vs 1.79 ± 0.17, p = 0.003). Hippocampal mGluR5 was negatively associated with hippocampal tau deposition ( r = −.46, p = 0.003) and positively associated with cognitive performance, but only in women. Hippocampal tau deposition mediated the effect of mGluR5 on cognitive performance. DISCUSSION Reduced hippocampal mGluR5 is negatively related with tau deposition in most cortical regions and positively associated with cognitive performance, making it a promising biomarker for AD diagnosis and therapy. Highlights Cognitively impaired (CI) patients exhibited lower metabotropic glutamate receptor 5 (mGluR5) availability in the hippocampus than cognitively unimpaired (CU) subjects. Hippocampal mGluR5 availability was negatively associated with tau deposition in widespread cortex. Hippocampal mGluR5 availability was positively associated with cognitive performance. The close association of mGluR5 with tau and cognition performance exists only in females. Tau pathology mediated the relationship between mGluR5 availability and cognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Central Research Institute, United Imaging Health Care Group Co., Ltd., Shanghai, China.
- Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China.
- Institute for Biomedical Engineering, Institute for Regenerative Medicine, University of Zurich & ETH Zurich, Zurich, Switzerland.
- Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Fang Xie
Förderung
- STI2030-Major Projects
- National Science Foundation of China
- Shanghai Sailing Program
- Huashan Hospital, Fudan University
- Shanghai Municipal Key Clinical Specialty
- Clinical Research Plan of SHDC
- Shanghai Municipal Science and Technology Major Project
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Wang, J., Chen, X., Lin, Z., You, Z., He, K., Guo, T., Zhao, J., Huang, Q., Ni, R., Guan, Y., Li, B., & Xie, F. (2025). Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70004
Vancouver
Wang Y, Wang J, Chen X, Lin Z, You Z, He K, et al. Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70004
BibTeX
@article{Wang2025,
author = {Wang, Yan and Wang, Jie and Chen, Xing and Lin, Zengping and You, Zhiwen and He, Kun and Guo, Tengfei and Zhao, Jun and Huang, Qi and Ni, Ruiqing and Guan, Yihui and Li, Binyin and Xie, Fang},
title = {Tau pathology is associated with postsynaptic metabotropic glutamate receptor 5 (mGluR5) in early Alzheimer's disease in a sex‐specific manner},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70004}
}
EUVIMED